Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: A population-based study

Clinical Infectious Diseases

Volumn 47, Issue 11, 2008, Pages 1367-1371

  Tsigrelis, Constantine ^a   Tleyjeh, Imad M ^a,b   Lahr, Brian D ^a   Nyre, Lisa M ^a   Virk, Abinash ^a   Baddour, Larry M ^a  

^a MAYO CLINIC   (United States)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; CHILD; FATALITY; HUMAN; INVASIVE PNEUMOCOCCAL DISEASE; MEDICAL RECORD REVIEW; MORTALITY; OTITIS MEDIA; PERITONITIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INCIDENCE; MIDDLE AGED; MINNESOTA; PNEUMOCOCCAL INFECTIONS;

EID: 55849096245     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592970     Document Type: Article

References (17)

1. Whitney CG, Farley MM, Hadler J, et al.; the Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737-46.
2. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784-92.
3. Albrich WC, Baughman W, Schmotzer B, Farley MM. Changing characteristics of invasive pneumococcal disease in metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007; 44:1569-76.
4. Byington CL, Samore MH, Stoddard GJ, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005; 41:21-9.
5. Hicks LA, Harrison LH, Flannery B, et al.; the Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196:1346-54.
6. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006; 295:1668-74.
7. Lexau CA, Lynfield R, Danila R, et al.; the Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294:2043-51.
8. Musher DM. Pneumococcal vaccine - direct and indirect ("herd") effects. N Engl J Med 2006; 354:1522-4.
9. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71:266-74.
10. Uslan DZ, Crane SJ, Steckelberg JM, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 2007; 167:834-9.
11. McNamara DR, Tleyjeh IM, Berbari EF, et al. Incidence of lower-extremity cellulitis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2007; 82:817-21.
12. Tleyjeh IM, Steckelberg JM, Murad HS, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005; 293:3022-8.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9.
14. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule - United States, October 2007-September 2008. MMWR Morb Mortal Wkly Rep 2007; 56:Q1-4. Available at: http://www.cdc.gov/mmwr/PDF/ wk/mm5641-Immunization.pdf.
15. Minnesota Department of Health. Influenza & pneumococcal vaccination rates for adults 65+. 18 October 2007. Available at: http://www.health. state.mn.us/divs/idepc/diseases/flu/flupneumo.html. Accessed 28 February 2008.
16. Centers for Disease Control and Prevention. Estimated vaccination coverage with individual vaccines and selected vaccination series among children 19-35 months of age by state and local area US, National Immunization Survey, Q1/2002-Q4/2006. 8 September 2008. Available at: http://www.cdc.gov/ vaccines/stats-surv/imz-coverage.htm#nis. Accessed 28 February 2008.
17. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007; 298:2155-63.